Advertisement

Tumor Biology

, Volume 33, Issue 2, pp 275–276 | Cite as

Minoru Toyota: a tribute

Tribute
  • 47 Downloads

References

  1. 1.
    Toyota M, Ho C, Ahuja N, Jair K-W, Ohe-Toyota M, Baylin SB, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 1999;59:2307–12.PubMedGoogle Scholar
  2. 2.
    Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JPJ. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96:8681–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Toyota M, Ohe-Toyota M, Ahuja N, Issa JP. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A. 2000;97:710–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999;59:5438–42.PubMedGoogle Scholar
  5. 5.
    Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP. Methylation profiling in acute myeloid leukemia. Blood. 2001;97:2823–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, et al. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology. 2005;129:156–69.PubMedCrossRefGoogle Scholar
  7. 7.
    Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus. Cancer. 2006;106:1467–79.PubMedCrossRefGoogle Scholar
  8. 8.
    Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008;68:4123–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, et al. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis. 2010;31(3):342–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Kamimae S, Yamamoto E, Yamano HO, Nojima M, Suzuki H, Ashida M, et al. Epigenetic alteration of DNA in mucosal wash fluids predicts invasiveness of colorectal tumors. Cancer Prev Res (Phila). 2011;4:674–83.CrossRefGoogle Scholar
  11. 11.
    Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 2010;17:510–22.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2012

Authors and Affiliations

  1. 1.Fels Institute for Cancer and Molecular BiologyTemple UniversityPhiladelphiaUSA

Personalised recommendations